Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
toxicity to reproduction
Remarks:
other: effects on fertility on parent animals
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Original reference not translated, and only short abstract available

Data source

Reference
Title:
No information
Author:
Malysheva MV, Saitzeva EP, Ivanov YuV (1983) Effects after dermal application with o-toluidine in rats. Gig Tr Prof Zabol 9: 47-49

Materials and methods

Principles of method if other than guideline:
Method: other: see TC
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
o-toluidine
EC Number:
202-429-0
EC Name:
o-toluidine
Cas Number:
95-53-4
Molecular formula:
C7H9N
IUPAC Name:
2-methylaniline
Details on test material:
IUCLID4 Test substance: other TS: o-toluidine, no data on purity

Test animals

Species:
rat
Strain:
not specified
Sex:
male/female

Administration / exposure

Route of administration:
dermal
Duration of treatment / exposure:
Exposure period: 4 month
Frequency of treatment:
4 h/day
Doses / concentrations
Remarks:
Doses / Concentrations:
8, 80 mg/kg bw
Basis:

Control animals:
yes

Results and discussion

Overall reproductive toxicity

Reproductive effects observed:
not specified

Any other information on results incl. tables

RS-Freetext:
Effects on treated animals (P):
---increased cell numbers of the spermatogenetic tissues
---no differences on spermatogenesis during the recovery period
---increased number of corpus luteum in ovaries
---no differences on fertility and number of implants observed

for effects on progeny (F1): see chapter 5.8.2

Applicant's summary and conclusion